South Korean actor Kim Soo-hyun is once again at the centre of controversy, with reports from India Today confirming that his segments on K-pop star G-Dragon's variety show, Good Day, have been ...

Republicans are at a crossroads heading into 2026, which will feature another Supreme Court race and contests for governor and state Legislature. MADISON – Susan Crawford's double-digit victory ...

And that’s good news, because it’s been confirmed the port will include 26 minutes of additional cutscenes long-time fans of the franchise will want to see. Yakuza obviously has a long ...

FIFA 19 THE JOURNEY CHAMPIONS GAMEPLAY! 1ST LOOK! OFFICIAL FIFA 19 JOURNEY CUT SCENES! Presented by EA Gamechangers CAN WE HIT 9,600 LIKES? FIFA 19 THE JOURNEY GAMEPLAY FIFA 19 THE JOURNEY FIFA 19 ...

The Capital Crossroads Special Improvement District in downtown Columbus will reduce its service territory due to budget cuts. The Capital Crossroads Special Improvement District will reduce its ...

SEGA and Ryu Ga Gotoku Studio have released some new details on Yakuza 0: Director’s Cut, revealing the game will boast 26 minutes of extra cutscenes to supplement the already-meaty narrative of ...

Among these are the brand-new cutscenes. Presumably, the original game’s static ... and anime online publications in the Philippines. Serving as the crossroads for anything and everything geek, UnGeek ...

Starbucks announces new barista dress code. Here's what it looks like Officials warn of 'urgent invasive species threat' in Northern California Actors Who Refused Game Of Thrones Roles Drone swarm ...

The action thriller L2: Empuraan featuring Mohanlal and Prithviraj faced backlash from Hindu Nationalist groups, leading to multiple scenes being cut. Mohanlal apologized and stated the film's ...

Lava Therapeutics N.V. (NASDAQ:LVTX), a clinical-stage biotechnology company with a market capitalization of $32.9 million, finds itself at a critical juncture following recent strategic shifts and ...

Lava Therapeutics N.V. (NASDAQ:LVTX), a clinical-stage biotechnology company with a market capitalization of $32.9 million, finds itself at a critical juncture following recent strategic shifts ...